6,15-Eicosadienoic acid, 20-hydroxy-, (6Z,15Z)-

6,15-Eicosadienoic acid, 20-hydroxy-, (6Z,15Z)- Suppliers list
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com
Company Name: Baimei Jihua (Henan) Pharmaceutical Technology Co., Ltd  
Tel: 0371-88900765 18037465274
Email: 3430974218@qq.com
Company Name: TargetMol Chemicals Inc.  
Tel: 4008200310 15002144251
Email: marketing@tsbiochem.com
Company Name: Pushan Industry (Shaanxi) Co., Ltd  
Tel: 029-81310890 18165209495
Email: 2929288192@qq.com
Company Name: Taizhou Chuanxu Pharmaceutical Technology Co., Ltd.  
Tel: chuanxupharma@126.co
Email: chuanxupharma@126.com
6,15-Eicosadienoic acid, 20-hydroxy-, (6Z,15Z)- Basic information
Product Name:6,15-Eicosadienoic acid, 20-hydroxy-, (6Z,15Z)-
Synonyms:6,15-Eicosadienoic acid, 20-hydroxy-, (6Z,15Z)-;WIT 002;20 HEDE,20HEDE;(6Z,15Z)-20-hydroxyicosa-6,15-dienoic acid;(6Z,15Z)-20-Hydroxy-6,15-eicosadienoic acid
CAS:240427-90-1
MF:C20H36O3
MW:324.5
EINECS:
Product Categories:
Mol File:240427-90-1.mol
6,15-Eicosadienoic acid, 20-hydroxy-, (6Z,15Z)- Structure
6,15-Eicosadienoic acid, 20-hydroxy-, (6Z,15Z)- Chemical Properties
storage temp. Store at -20°C
solubility Soluble in DMSO
form Liquid
color Off-white to yellow
Safety Information
MSDS Information
6,15-Eicosadienoic acid, 20-hydroxy-, (6Z,15Z)- Usage And Synthesis
Uses20-HEDE (WIT 002) is an antagonist of 20-hydroxyeicosatetraenoic acid (20-HETE).
DefinitionChEBI: 20-HeDE is a long-chain fatty acid.
in vivo

The effect of the 20-HETE antagonist, WIT 002 on the growth of 786-O clear cell renal carcinoma is assessed in ectopic mouse model of renal tumor. The growth of tumors is significantly suppressed by WIT 002 administered daily to athymic nude mice implanted subcutaneously with cells 786-O. Tumor growth is inhibited by 84%±128%. It is of note that in these experiments WIT 002 treatment start only after the tumor is seeded for 7-14 days and is relatively large 0.1 cm. Thus, WIT 002 is effective at arresting the growth of a fairly advanced tumor[3].

References[1] Ming Yua . et al. Effects of a 20-HETE antagonist and agonists on cerebral vascular tone. Eur J Pharmacol. 2004 Feb 23;486(3):297-306. DOI:10.1016/j.ejphar.2004.01.009
[2] Wei Yu, et al. Cytochrome P450 ω-hydroxylase promotes angiogenesis and metastasis by upregulation of VEGF and MMP-9 in non-small cell lung cancer. Cancer Chemother Pharmacol. 2011 Sep; 68(3): 619-29. DOI:10.1007/s00280-010-1521-8
[3] Anna Alexanian, et al. Down-regulation of 20-HETE Synthesis and Signaling Inhibits Renal Adenocarcinoma Cell Proliferation and Tumor Growth. Anticancer Res. 2009 October ; 29(10): 3819-3824. PMID:19846914
6,15-Eicosadienoic acid, 20-hydroxy-, (6Z,15Z)- Preparation Products And Raw materials
Tag:6,15-Eicosadienoic acid, 20-hydroxy-, (6Z,15Z)-(240427-90-1) Related Product Information
HET0016 Apigenin STIRIPENTOL Hypericin Cepharanthine Atovaquone